Health Beat: Feds Should Stop Restricting Medical Marijuana Research

Allergies — there are pills for that. Back pain, headaches — pills for those too.

These days it’s almost impossible to think of a medical condition for which not one Food and Drug Administration-approved pill exists for treatment.

So why haven’t scientists done enough research on the active ingredients in marijuana so that pharmaceutical companies could make a pill delivering well-regulated amounts of the beneficial qualities of medical cannabis?

With the increased acceptance of the medicinal qualities of cannabis, it just doesn’t make sense to have this substance stay on the federal Drug Enforcement Agency’s Schedule 1 list, thus prohibiting any research into its benefit for various medical conditions.

After all, Big Pharma has developed a pill for basically everything else!

There are FDA-approved pills for almost every medical condition, but not to deliver the benefits of medical marijuana.

Pöllö via Wikimedia Commons

The lack of research has led to the need to have alternative methods of ingestion, such as smoking or eating marijuana directly. This has led to several dilemmas. First of which, smoking is bad for your health, as some of the same toxins, irritants and carcinogens come with smoking marijuana just like smoking tobacco.

So without any data on the helpful effects of smoking marijuana, it’s hard to know if there are any adverse effects. There’s also no control over the dose, because once again, research is lacking on the appropriate prescribing amount based on the medical diagnosis being treated.

The lack of research has also led to alternative products being sold that may not have any of the active ingredients necessary to actually treat a medical condition.

An online search will find CBD pills touted to be organically grown and THC pills that are supposedly medical grade. But you’ve got to question the

Read More Here...

Bookmark the permalink.